Financial PerformanceMolina Healthcare Inc. maintains a positive 2024 adjusted EPS guidance, expressing confidence in its longer-term outlook.
Market ValuationWith the stock trading at a discount to its 3-year average, the analyst maintains a Buy rating.
Membership And Revenue GrowthPremium revenue grew +20.5% year-over-year, and total medical membership increased significantly, mainly driven by Medicaid.